Metastatic Breast Cancer Updates: SERDs, mTOR Inhibitors, and VIKTORIA-1

18 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Erika Hamilton, MD, and Sarah Premji, MD, of Sarah Cannon Research Institute, discuss presentations from ESMO Congress 2025 on the evERA, VIKTORIA-1, and SERENA-6 trials in HR-positive advanced breast cancer.

Follow us on social media:
•⁠ ⁠X/Twitter: https://twitter.com/oncbrothers
•⁠ ⁠Instagram: https://www.instagram.com/oncbrothers
•⁠ Website: https://oncbrothers.com/
•⁠ Main Channel: https://www.youtube.com/@UCjfxKlVho5xWH5ltufj4F4A
Categoria
Oncology
Commenta per primo questo video.

Prossimo